DAINI, ELEONORA
DAINI, ELEONORA
Dipartimento di Scienze Biomediche, Metaboliche e Neuroscienze
A regional and cellular analysis of the early intracellular and extracellular accumulation of Aβ in the brain of 5XFAD mice
2021 Daini, E.; Secco, V.; Liao, W.; Zoli, M.; Vilella, A.
DAT atypical inhibitors as novel antipsychotic drugs
2019 Daini, Eleonora; Linciano, Pasquale; Sorbi, Claudia; Grilli, Massimo; Zoli, Michele; Franchini, Silvia; Vilella, Antonietta
H3.3A e H3.3B: distribuzione regionale ed espressione cellulare delle isoforme della variante istonica H3.3 in diverse condizioni fisiologiche
2020 Daini, Eleonora
Identification of a Thyroid Hormone Derivative as a Pleiotropic Agent for the Treatment of Alzheimer’s Disease
2021 Runfola, M.; Perni, M.; Yang, X.; Marchese, M.; Bacci, A.; Mero, S.; Santorelli, F. M.; Polini, B.; Chiellini, G.; Giuliani, D.; Vilella, A.; Bodria, M.; Daini, E.; Vandini, E.; Rudge, S.; Gul, S.; Wakelam, M. O. J.; Vendruscolo, M.; Rapposelli, S.
Melanocortin receptor agonist NDP-α-MSH improves cognitive deficits and microgliosis but not amyloidosis in advanced stages of AD progression in 5XFAD and 3xTg mice
2023 Daini, E.; Vandini, E.; Bodria, M.; Liao, W.; Baraldi, C.; Secco, V.; Ottani, A.; Zoli, M.; Giuliani, D.; Vilella, A.
Nanomedicine against Aβ aggregation by β–sheet breaker peptide delivery: In vitro evidence
2019 Pederzoli, F.; Ruozi, B.; Duskey, J.; Hagmeyer, S.; Sauer, A. K.; Grabrucker, S.; Coelho, R.; Oddone, N.; Ottonelli, I.; Daini, E.; Zoli, M.; Vandelli, M. A.; Tosi, G.; Grabrucker, A. M.
PCSK9 ablation attenuates Aβ pathology, neuroinflammation and cognitive dysfunctions in 5XFAD mice
2024 Vilella, A.; Bodria, M.; Papotti, B.; Zanotti, I.; Zimetti, F.; Remaggi, G.; Elviri, L.; Poti, F.; Ferri, N.; Lupo, M. G.; Panighel, G.; Daini, E.; Vandini, E.; Zoli, M.; Giuliani, D.; Bernini, F.
PLGA-PEG-ANG-2 Nanoparticles for Blood-Brain Barrier Crossing: Proof-of-Concept Study
2020 Hoyos-Ceballos, Gina P; Ruozi, Barbara; Ottonelli, Ilaria; Da Ros, Federica; Vandelli, Maria Angela; Forni, Flavio; Daini, Eleonora; Vilella, Antonietta; Zoli, Michele; Tosi, Giovanni; Duskey, Jason T; López-Osorio, Betty L
S100B dysregulation during brain development affects synaptic SHANK protein networks via alteration of zinc homeostasis
2021 Daini, E.; Hagmeyer, S.; De Benedictis, C. A.; Cristovao, J. S.; Bodria, M.; Ross, A. M.; Raab, A.; Boeckers, T. M.; Feldmann, J.; Gomes, C. M.; Zoli, M.; Vilella, A.; Grabrucker, A. M.
Targeting Metal Homeostasis as a Therapeutic Strategy for Alzheimer’s Disease
2020 Vilella, Antonietta; Daini, Eleonora; De Benedictis, Chiara A.; Grabrucker, Andreas M.
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| A regional and cellular analysis of the early intracellular and extracellular accumulation of Aβ in the brain of 5XFAD mice | 1-gen-2021 | Daini, E.; Secco, V.; Liao, W.; Zoli, M.; Vilella, A. | |
| DAT atypical inhibitors as novel antipsychotic drugs | 1-gen-2019 | Daini, Eleonora; Linciano, Pasquale; Sorbi, Claudia; Grilli, Massimo; Zoli, Michele; Franchini, Silvia; Vilella, Antonietta | |
| H3.3A e H3.3B: distribuzione regionale ed espressione cellulare delle isoforme della variante istonica H3.3 in diverse condizioni fisiologiche | 19-mar-2020 | Daini, Eleonora | |
| Identification of a Thyroid Hormone Derivative as a Pleiotropic Agent for the Treatment of Alzheimer’s Disease | 1-gen-2021 | Runfola, M.; Perni, M.; Yang, X.; Marchese, M.; Bacci, A.; Mero, S.; Santorelli, F. M.; Polini, B.; Chiellini, G.; Giuliani, D.; Vilella, A.; Bodria, M.; Daini, E.; Vandini, E.; Rudge, S.; Gul, S.; Wakelam, M. O. J.; Vendruscolo, M.; Rapposelli, S. | |
| Melanocortin receptor agonist NDP-α-MSH improves cognitive deficits and microgliosis but not amyloidosis in advanced stages of AD progression in 5XFAD and 3xTg mice | 1-gen-2023 | Daini, E.; Vandini, E.; Bodria, M.; Liao, W.; Baraldi, C.; Secco, V.; Ottani, A.; Zoli, M.; Giuliani, D.; Vilella, A. | |
| Nanomedicine against Aβ aggregation by β–sheet breaker peptide delivery: In vitro evidence | 1-gen-2019 | Pederzoli, F.; Ruozi, B.; Duskey, J.; Hagmeyer, S.; Sauer, A. K.; Grabrucker, S.; Coelho, R.; Oddone, N.; Ottonelli, I.; Daini, E.; Zoli, M.; Vandelli, M. A.; Tosi, G.; Grabrucker, A. M. | |
| PCSK9 ablation attenuates Aβ pathology, neuroinflammation and cognitive dysfunctions in 5XFAD mice | 1-gen-2024 | Vilella, A.; Bodria, M.; Papotti, B.; Zanotti, I.; Zimetti, F.; Remaggi, G.; Elviri, L.; Poti, F.; Ferri, N.; Lupo, M. G.; Panighel, G.; Daini, E.; Vandini, E.; Zoli, M.; Giuliani, D.; Bernini, F. | |
| PLGA-PEG-ANG-2 Nanoparticles for Blood-Brain Barrier Crossing: Proof-of-Concept Study | 1-gen-2020 | Hoyos-Ceballos, Gina P; Ruozi, Barbara; Ottonelli, Ilaria; Da Ros, Federica; Vandelli, Maria Angela; Forni, Flavio; Daini, Eleonora; Vilella, Antonietta; Zoli, Michele; Tosi, Giovanni; Duskey, Jason T; López-Osorio, Betty L | |
| S100B dysregulation during brain development affects synaptic SHANK protein networks via alteration of zinc homeostasis | 1-gen-2021 | Daini, E.; Hagmeyer, S.; De Benedictis, C. A.; Cristovao, J. S.; Bodria, M.; Ross, A. M.; Raab, A.; Boeckers, T. M.; Feldmann, J.; Gomes, C. M.; Zoli, M.; Vilella, A.; Grabrucker, A. M. | |
| Targeting Metal Homeostasis as a Therapeutic Strategy for Alzheimer’s Disease | 1-gen-2020 | Vilella, Antonietta; Daini, Eleonora; De Benedictis, Chiara A.; Grabrucker, Andreas M. |